Liminal Biosciences
Belleville, CA · 1 known investors
Find your way into Liminal Biosciences
Liminal BioSciences, through subsidiary CALEDON BIOSCIENCE, discovers and develops small molecule therapeutics targeting G protein-coupled receptor pathways for metabolic, inflammatory, and fibrotic diseases. The company applies drug discovery and medicinal chemistry expertise to create novel therapeutic candidates in underexplored GPCR pathways.
Founders & leadership
B
BruceChief Executive Officer
Investors · 1
In the news
Frequently asked questions
- What does Liminal Biosciences do?
- Liminal BioSciences, through subsidiary CALEDON BIOSCIENCE, discovers and develops small molecule therapeutics targeting G protein-coupled receptor pathways for metabolic, inflammatory, and fibrotic diseases. The company applies drug discovery and medicinal chemistry expertise to create novel therapeutic candidates in underexplored GPCR pathways.
- Who are Liminal Biosciences's investors?
- Liminal Biosciences's investors include AmorChem.
- Where is Liminal Biosciences headquartered?
- Liminal Biosciences is headquartered in Belleville, CA.